Intra Aortic Balloon Pump Market - By Component: IABP Consoles, IABP Catheters; By Application: Cardiogenic Shock, Acute Myocardial Infarction, Post-CABG,Others (High-Risk PCI, Heart Failure); By End User: Hospitals, Cardiac Intensive Care Units (CICUs), Specialty Heart Centers; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global intra-aortic balloon pump (IABP) market is driven by the increasing prevalence of cardiovascular diseases, particularly acute myocardial infarction, cardiogenic shock, and complications following coronary artery bypass grafting (CABG). IABPs are mechanical devices that temporarily support the heart’s function and reduce its workload by inflating and deflating a balloon in the aorta, improving coronary perfusion and cardiac output.
The demand for IABPs remains strong in both emergency and perioperative care settings. Technological advancements in catheter materials, sheathless insertion, and portable console systems are enhancing safety and ease of use. Although the use of IABPs has declined slightly in some developed nations due to evolving clinical guidelines and newer ventricular assist options, emerging markets and surgical cardiac ICUs continue to demonstrate strong adoption.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
0.88 |
Historical benchmark |
|
2024 |
1.22 |
Five-year CAGR 6.8% |
|
2031 |
1.94 |
Seven-year CAGR 6.8% |
The market is anticipated to grow steadily through 2031, fueled by enhanced access to cardiac care in emerging regions and broadening post-operative cardiac support protocols.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The IABP market is consolidated, with a few global players offering advanced consoles and balloon catheters.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Getinge AB (Maquet) |
47% |
Cardiosave® IABP, Sensation Plus® Catheters |
|
Teleflex Incorporated |
19% |
Arrow® IAB Catheters and accessories |
|
Tokai Medical |
12% |
Japanese-manufactured balloon pumps and kits |
|
Others (regional suppliers, startups) |
22% |
Local offerings in Asia-Pacific and LATAM |
6 | Market Segmentation
By Component:
By Application:
By End User:
By Region:
7 | Strategic Outlook
While newer mechanical circulatory support options challenge IABPs in some markets, they remain indispensable in cost-sensitive and emergency cardiac care settings. Key growth strategies include regional manufacturing expansion, clinician education programs, and integration of IABP consoles with remote monitoring platforms.
Need help?
Chat with our team in a minute.